000			01505 a2200421 4500
005			20250513040428.0
264		0	_c19930916
008			199309s 0 0 eng d
022			_a0021-9258
040			_aNLM _beng _cNLM
100	1		_aReardon, D B
245	0	0	_aDownstream signal transduction defects that suppress transformation in two revertant cell lines expressing activated rat neu oncogene. _h[electronic resource]
260			_bThe Journal of biological chemistry _cAug 1993
300			_a18136-42 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
650	0	4	_a3T3 Cells
650	0	4	_aAnimals
650	0	4	_aBlotting, Southern
650	0	4	_aCell Division _xdrug effects
650	0	4	_aCell Line, Transformed
650	0	4	_aCell Transformation, Neoplastic
650	0	4	_aDNA _xgenetics
650	0	4	_aEthyl Methanesulfonate _xtoxicity
650	0	4	_aMice
650	0	4	_aMutagenesis
650	0	4	_aOncogenes
650	0	4	_aPhosphotyrosine
650	0	4	_aProtein-Tyrosine Kinases _xbiosynthesis
650	0	4	_aProto-Oncogene Proteins _xbiosynthesis
650	0	4	_aProto-Oncogenes
650	0	4	_aReceptor, ErbB-2
650	0	4	_aReceptors, Cell Surface _xbiosynthesis
650	0	4	_aRestriction Mapping
650	0	4	_aSignal Transduction
650	0	4	_aTyrosine _xanalogs & derivatives
700	1		_aHung, M C
773	0		_tThe Journal of biological chemistry _gvol. 268 _gno. 24 _gp. 18136-42
999			_c7688162 _d7688162